Research progress on the clinical application of PCSK9 inhibitors in coronary heart disease

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 6

Abstract

Coronary heart disease (CHD) is currently an important cause of mortality among residents in China and worldwide. The incidence of CHD in China is increasing annually. Among the various factors leading to the occurrence of CHD, abnormalities in blood lipids, especially elevated low-density lipoprotein cholesterol(LDL-C), are particularly significant. Epidemiological, genetic, and clinical studies have confirmed its crucial role in the development of CHD. Therefore, effectively controlling LDL-C levels has become paramount in preventing the onset of CHD and reducing mortality rates. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, as novel lipid-lowering medications, effectively lower LDL-C and play a significant role in preventing major adverse cardiovascular events(MACEs). This article provides a review of PCSK9 inhibitors in clinical treatment related to coronary artery atherosclerosis.

Authors and Affiliations

CHEN Renliang, CHEN Fengying

Keywords

Related Articles

Construction of a predictive model for fever in elderly patients after endoscopic mucosal dissection surgery

Objective To analyze the risk factors for postoperative fever in elderly patients after endoscopic mucosal dissection (ESD), and construct a predictive model. Methods The research subjects were 500 elderly patients who...

Research progress on the mechanism of action of gut microbiota on hepatocellular carcinoma

Hepatocellular carcinoma (HCC) has a high incidence rate among the malignant tumors reported in the world, and its incidence rate and mortality continue to rise. In recent years, researches have shown that the gut microb...

Clinical significance and research progress of microsatellite instability in gastric cancer

The occurrence and development of gastric cancer (GC) is determined by many factors. In recent years, the development of molecular biology has provided new ideas for the diagnosis and treatment of GC. Microsatellite inst...

Application of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament in bariatric surgery

Objective To compare the analgesic effect of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament (QLB-LSAL) and transversus abdominis plane block (TAPB) in laparoscopic sleeve gastr...

Influencing factors of pathological complete response in triple-negative breast cancer with neoadjuvant chemotherapy

Objective To analyze the clinical and pathological factors affecting pathological complete response (pCR) of triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NAC).  Methods A retrospective analysis wa...

Download PDF file
  • EP ID EP738304
  • DOI 10.13429/j.cnki.cjcr.2024.06.002
  • Views 24
  • Downloads 0

How To Cite

CHEN Renliang, CHEN Fengying (2024). Research progress on the clinical application of PCSK9 inhibitors in coronary heart disease. Chinese Journal of Clinical Research, 37(6), -. https://europub.co.uk/articles/-A-738304